Skip to main content

Table 4 Table shows the odds ratio of reactivity against different cit-Fib peptides and genetic risk allels in RA (HLA-DR SE and PTPN22 risk allele)

From: Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells

 

Cit-Fib α 35

Cit-Fib α 216,218

Cit-Fib α 263,271

Cit-Fib α 425,426

Cit-Fib protein

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

SE

1.6 (0.8–3.2)

0.21

0.7 (0.3–1.4)

0.31

1.3 (0.7–2.6)

0.39

1.4 (0.7–2.9)

0.37

2.1 (1.2–3.5)

0.008

PTPN22

1.8 (1–3.1)

0.04

0.6 (0.3–1.2)

0.14

2.0 (1.1–3.4)

0.02

1.6 (0.9–2.8)

0.14

2.1 (1.3–3.5)

0.002

  1. cit-Fib citrullinated fibrinogen, RA rheumatoid arthritis, SE shared epitope
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us